




Searching News Database: Dry Eye Disease
HSMN NewsFeed - 15 Jul 2024
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
HSMN NewsFeed - 21 Sep 2020
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
HSMN NewsFeed - 7 May 2020
Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
HSMN NewsFeed - 29 Jan 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
HSMN NewsFeed - 15 May 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
HSMN NewsFeed - 10 May 2018
Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
HSMN NewsFeed - 24 Apr 2018
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
HSMN NewsFeed - 19 Oct 2017
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
HSMN NewsFeed - 8 May 2017
Lamellar Biomedical Raises £5.75 Million in Series C Fund Raising led by Invesco
Lamellar Biomedical Raises £5.75 Million in Series C Fund Raising led by Invesco
HSMN NewsFeed - 2 May 2017
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears(TM)
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears(TM)
HSMN NewsFeed - 16 May 2016
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
HSMN NewsFeed - 4 May 2016
Notal Vision Announces Appointment of Quinton Oswald as Chief Executive Officer
Notal Vision Announces Appointment of Quinton Oswald as Chief Executive Officer
HSMN NewsFeed - 23 Jul 2014
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
HSMN NewsFeed - 19 May 2014
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
HSMN NewsFeed - 1 Feb 2012
TearScience Achieves FDA Clearance for Second Generation LipiFlow(R) Thermal Pulsation System
TearScience Achieves FDA Clearance for Second Generation LipiFlow(R) Thermal Pulsation System
HSMN NewsFeed - 29 Nov 2011
InSite Vision Wins Patent Interference Litigation Against the University of California, San Francisco
InSite Vision Wins Patent Interference Litigation Against the University of California, San Francisco
HSMN NewsFeed - 15 Aug 2011
TearScience(R) Appoints Diethart Reichardt as Senior Vice President of European Region
TearScience(R) Appoints Diethart Reichardt as Senior Vice President of European Region
HSMN NewsFeed - 21 Dec 2010
TearScience Wins SEBIO Award for Securing $44.5 Million in Venture Funding in 2010
TearScience Wins SEBIO Award for Securing $44.5 Million in Venture Funding in 2010
HSMN NewsFeed - 19 May 2009
TearLab Corporation Announces FDA 510(k) Clearance of the TearLab(tm) Osmolarity System
TearLab Corporation Announces FDA 510(k) Clearance of the TearLab(tm) Osmolarity System
Additional items found! 4

Members Archive contains
4 additional stories matching:
Dry Eye Disease
(Password required)
Dry Eye Disease
(Password required)